Spinal Cord Stimulation Devices Market Report 2025 (Global Edition)

Global Spinal Cord Stimulation Devices Market Report 2025 Market Size Split by Indication (Failed back surgery syndrome, Complex regional pain syndrome, Degenerative disc disease, Others), by Product ...

Spinal Cord Stimulation Devices Market Report Description

We have various report editions of Spinal Cord Stimulation Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Spinal Cord Stimulation Devices Market Insights Video

Competitive Landscape of the Spinal Cord Stimulation Devices Market

In the market for spinal cord stimulator devices, some of the well-known companies include Boston Scientific Corp., Nevro Corp., Abbott Laboratories, Cirtec Medical Corp., Medtronic P/c., Biotronik SE & Co KG., Curonix LLC., Nalu Medical, Inc., and Synapse Biomedical Inc. To satisfy demand from customers worldwide and broaden their product offerings in niche portfolios, these businesses concentrate on launching new products and expanding their geographic reach. Due to their extensive customer base and global reach, they are able to support market expansion.

October 2022: Global medical device manufacturer Nevro Corp., which provides comprehensive, game-changing solutions for the treatment of chronic pain, announced that the FDA in the United States has expanded its manufacturing operations in Costa Rica to produce its proprietary spinal cord stimulation systems, which include the HFX product platform, for the treatment of chronic pain. (Source: https://nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Announces-FDA-Approval-of-Costa-Rica-Manufacturing-Operations/default.aspx ) August 2022: The US FDA approved Abbott Laboratories' Proclaim Plus SCS system to treat chronic pain. The gadget provides excellent pain alleviation because of BurstDR stimulation technology. It provides FlexBurst360 therapy, which covers discomfort in the trunk and limbs. The device can be adjusted to meet the patient's changing needs for therapy. (Source: https://abbott.mediaroom.com/2022-08-23-FDA-Approves-Abbotts-New-Spinal-Cord-Stimulation-Device-Provides-Tailored-Relief-to-Multiple-Pain-Areas-and-Adds-More-Treatment-Options-for-Evolving-Pain-Conditions ) January 2022: The FDA has approved Medtronic Plc, a pioneer in medical technology worldwide, to treat chronic pain linked to diabetic peripheral neuropathy (DPN) with its rechargeable Intellis neurostimulator and rechargeable non-rechargeable Vanta neurostimulator. (Source: https://news.medtronic.com/2022-01-24-Medtronic-announces-FDA-approval-of-spinal-cord-stimulation-therapy-for-treating-chronic-pain-resulting-from-diabetic-peripheral-neuropathy ) January 2021: The Spinal Cord Stimulator (SCS) system line from WaveWriter Alpha has been made available to a limited market by Boston Scientific. Fast Acting Sub-Perception Therapy (FAST), which is intended to provide significant paresthesia-free pain relief in minutes, is offered for the first time in SCS, along with a unified portfolio of four MRI conditional, Bluetooth-enabled, rechargeable and non-rechargeable implantable pulse generators (IPGs) that offer intact personalization. (Source: https://news.bostonscientific.com/2021-01-14-Boston-Scientific-Launches-WaveWriter-Alpha-TM-Spinal-Cord-Stimulator-Systems-In-U-S )

Top Companies Market Share in Spinal Cord Stimulation Devices Industry: (In no particular order of Rank)

• Boston Scientific Corporation
• Teliatry
• Inc.
• Medtronic plc
• Nevro Corporation
• Biotronik SE & Co KG.
• Curonix LLC.
• Nalu Medical
• Inc.
• Synapse Biomedical Inc.
• Saluda Medical Pty Ltd.
• Abbott Laboratories
• GIMER MEDICAL
• Cirtec Medical Corp.
• Beijing PINS Medical Co.
• Ltd
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Spinal Cord Stimulation Devices Market

Which Region Dominates the Spinal Cord Stimulation Devices Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue driven by a more developed infrastructure for healthcare, an increase in the frequency of chronic pain disorders, and a growing uptake of cutting-edge medical technologies. The region leads the world in spinal cord stimulation device sales due to favorable reimbursement policies and high healthcare costs.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Spinal Cord Stimulation Devices market driven by the growing number of patients with chronic pain conditions, rising healthcare costs, and developing healthcare infrastructure in emerging markets. The region's market is expanding due to increased investments in healthcare technology and a greater emphasis on addressing unmet medical requirements.

The current report Scope analyzes Spinal Cord Stimulation Devices Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Spinal Cord Stimulation Devices Market

According to Cognitive Market Research, the global Spinal Cord Stimulation Devices market size was estimated at USD 3125.6 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 1250.24 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Spinal Cord Stimulation Devices market with a market size of USD 986.44 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period encouraged by government programs that are supportive and the increasing public awareness of spinal cord stimulation treatments.
• The Canada Spinal Cord Stimulation Devices market had a market share of USD 150.03 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. The region's market expansion is further supported by the existence of significant market players as well as continuing research and development initiatives.
• The Mexico Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 113.77 million in 2024.

Europe Spinal Cord Stimulation Devices Market

According to Cognitive Market Research, the global Spinal Cord Stimulation Devices market size was estimated at USD 3125.6 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 937.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.

• The United Kingdom Spinal Cord Stimulation Devices market had a market share of USD 157.53 million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period driven by developing improved pain management solutions markets and changing healthcare systems.
• The France Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 86.27 million in 2024.
• According to Cognitive Market Research, the German Spinal Cord Stimulation Devices market size was valued at USD 185.66 million in 2024 and is projected to grow at a CAGR of 6.7% during the forecast period driven by the growing number of patients with chronic pain conditions and the increase in healthcare costs.
• The Italy Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 5.9% during the forecast period, with a market size of USD 80.64 million in 2024.
• The Russia Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 145.34 million in 2024.
• The Spain Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 5.6% during the forecast period with a market size of USD 76.89 million in 2024
• The Luxembourg Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 29.07 million in 2024.
• The Portugal Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 19.69 million in 2024.
• The Greece Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 11.25 million in 2024.
• Rest of Europe's Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 145.34 million in 2024.

Asia Pacific Spinal Cord Stimulation Devices Market

According to Cognitive Market Research, the global Spinal Cord Stimulation Devices market size was estimated at USD 3125.6 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 718.89 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Spinal Cord Stimulation Devices market size was valued at USD 323.50 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period motivated by supportive government initiatives and growing public knowledge of spinal cord stimulation therapies.
• The Japan Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 99.21 million in 2024.
• The India Spinal Cord Stimulation Devices market had a market share of USD 86.27 million in 2024 and is projected to grow at a CAGR of 11.8% during the forecast period. The presence of major market participants and ongoing R&D projects help the region's market expansion even further.
• The South Korean Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD 71.89 million in 2024.
• The Australian Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 37.38 million in 2024.
• The South East Asia Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 11.0% during the forecast period, with a market size of USD 49.60 million in 2024.
• The Rest of Asia Pacific Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 51.04 million in 2024.

South America Spinal Cord Stimulation Devices Market

According to Cognitive Market Research, the global Spinal Cord Stimulation Devices market size was estimated at USD 3125.6 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 156.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil Spinal Cord Stimulation Devices market size was valued at USD 66.89 million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period driven by markets for bettering pain management products and evolving healthcare structures.
• Argentina's Spinal Cord Stimulation Devices market had a market share of USD 26.26 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period driven by the rise in healthcare expenses and the number of patients suffering from chronic pain disorders.
• Colombia Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 13.91 million in 2024.
• Peru Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 12.81 million in 2024.
• Chile Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 11.25 million in 2024.
• The Rest of Latin America's Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 25.16 million in 2024.

Middle East and Africa Spinal Cord Stimulation Devices Market

According to Cognitive Market Research, the global Spinal Cord Stimulation Devices market size was estimated at USD 3125.6 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 62.51 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031..

• The GCC Countries Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 26.76 million in 2024 driven by consumer demand for improved pain relief solutions and changing healthcare delivery models.
• The Egypt Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 6.56 million in 2024.
• The South Africa Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 9.88 million in 2024 driven by the increase of patients experiencing chronic pain conditions and the cost of healthcare.
• The Turkey Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 5.38 million in 2024.
• The Nigeria Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 6.56 million in 2024.
• The Rest of MEA Spinal Cord Stimulation Devices market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 7.38 million in 2024.

Spinal Cord Stimulation Devices Market Analysis

Spinal Cord Stimulation Devices Market Indication Segment Analysis

According to Cognitive Market Research, complex regional pain syndrome stands out as the dominant category over the projected period. Prolonged pain and inflammation brought on by an accident or other medical occurrences, such as surgery, trauma, stroke, or heart attack, are referred to as complex regional pain syndrome, or CRPS. Anywhere in the body might experience CRPS, however, it typically affects the arm, leg, hand, or foot. Anyone at any age is more prone to experience it, and after 40 years, the inflammation is likely to reach its height. The majority of cases of chronic regional pain syndrome are brought on by impaired or injured tiny peripheral C-fiber nerve fibers, which transmit pain signals to the brain. Little clots that form in CRPS frequently go undetected, occasionally damaging the nerve by obstructing blood flow.

Failed back surgery syndrome emerges as the fastest-growing category in the Spinal Cord Stimulation Devices market. Treatment of failed back syndrome, a disease in which individuals still have pain after spine surgery, is one important application. By sending electrical impulses to the spinal cord, spinal cord stimulation helps reduce this ongoing discomfort by preventing pain signals from traveling to the brain.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Spinal Cord Stimulation Devices Industry. Request a Free Sample PDF!

Spinal Cord Stimulation Devices Market Product Segment Analysis

According to Cognitive Market Research, the dominant category is rechargeable devices. An implanted device called a spinal cord stimulator delivers low-magnitude electrical signals straight into the spinal cord to relieve pain. Most often, spinal cord stimulation is used when nonsurgical pain management techniques are insufficient in relieving pain. In the past, a number of leading manufacturers have introduced novel rechargeable spinal cord stimulation equipment. The US Food and Drug Administration (FDA) gave Abbott certification in December 2022 for the world's smallest implanted, rechargeable spinal cord stimulation system intended for chronic pain. (Source: https://www.prnewswire.com/news-releases/abbott-launches-the-worlds-smallest-implantable-rechargeable-spinal-cord-stimulation-system-for-chronic-pain-301705855.html )

The fastest-growing category in the Spinal Cord Stimulation Devices market is non-rechargeable devices. Spinal cord stimulation devices that do not require recharging are appreciated for their affordability and ease of use despite the need for regular battery changes. They are usually used when a patient has more immediate needs for pain relief or when the device might not be used all the time. By meeting the various demands and preferences of patients and attempting to improve quality of life through efficient pain management solutions, both kinds of devices add to the ever-changing spinal cord stimulation industry.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Spinal Cord Stimulation Devices End-user Segment Analysis

Spinal Cord Stimulation Devices Market End-user Segment Analysis

According to Cognitive Market Research, the dominant category is hospitals. In order to treat patients with spinal cord injuries (SCIs), hospitals frequently use spinal cord stimulation equipment. Patients have a short surgery, usually performed as an outpatient procedure, to implant these devices and then stay overnight in the hospital. The spinal cord stimulator, which reduces chronic pain by sending mild electrical pulses directly into the patient's nerve fibers after implantation, is one implantable device that the hospital infrastructure is well-suited to use.

The fastest-growing category in the Spinal Cord Stimulation Devices market is ambulatory surgical centers. A major factor in this growth has been the growing need for less invasive operations, many of which are carried out in ASCs. With shorter recovery times and fewer infection risks than standard hospital settings, these facilities are an affordable, effective option that appeals to both patients and medical professionals.

• Hospitals
• Ambulatory surgical centers
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion